Resected non-small-cell lung cancer stage I/II: Indication for adjuvant/neoadjuvant therapy?

Lung Cancer

Volumn 45, Issue SUPPL. 2, 2004, Pages

  Hoffmann, Hans ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adjuvant therapy; Neo adjuvant therapy; Non small cell lung cancer (NSCLC); Radotherapy; Surgery Chemotherapy

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; MITOMYCIN; PACLITAXEL; PLATINUM DERIVATIVE; UFT; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG TOLERABILITY; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 8444252219     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.07.986     Document Type: Conference Paper

References (26)

1. Mountain C.F. Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
2. Suzuki K., Nagai K., and Yoshida J. Prognostic factors in clinical stage I non-small cell lung cancer Ann Thorac Surg 67 1999 927 932
3. Pisters K.M. The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancer Sem Radiat Oncol 10 2000 274 279
4. Sakao Y., Sakuragi T., and Natsuaki M. Clinicopathological analysis of prognostic factors in clinical stage la peripheral adenocarcinoma of the lung Ann Thorac Surg 75 2003 1113 1117
5. Japanese Joint Committee of Lung Cancer Registry, Shirakusa T., and Kobayashi K. Lung Cancer in Japan: an analysis of lung cancer registry for resected cases in 1994 Jpn J Lung Cancer 42 2002 555 566
6. Feld R., Rubinstein L.V., and Weisenberger T.H. Sites of recurrence in resected stage I non-small cell lung cancer: a guide for future studies J Clin Oncol 2 1994 1352 1358
7. Nowak A.K., Robinson B.W., and Lake R.A. Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors Cancer Res 63 2003 4490 4496
8. Nowak A.K., Lake R.A., and Marzo A.L. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells J Immunol 170 2003 4905 4913
9. Keller S.M., Vangel M.G., and Wagner H. Second primary tumors following adjuvant therapy of resected stages II and IIIa nonsmall cell lung cancer Lung Cancer 42 2003 79 86
10. Rice D., Kim H.W., and Sabichi A. The risk of second primary tumors after resection of stage I non-small cell lung cancer Ann Thorac Surg 76 2003 1001 1007
11. Van Houtte P., Rocmans P., and Smets P. Post-operative radiation therapy in lung cancer: a controlled trial after resection of curative design Int J Radiat Oncol Biol Phys 6 1980 938 986
12. PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small cell lung cancer: a systematic review and meta-analysis of individual patient data from nine randomized controlled trials Lancet 352 1998 257 263
13. Trodella L., Granone P., and Valente S. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial Radiother Oncol 62 2002 11 19
14. Lung Cancer Study Group Effects of post-operative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung N Engl J Med 315 1986 1377 1381
15. Feng Q.F., Wang M., and Wang L.J. A study of postoperative radiotherapy in patients with non-small cell lung cancer: a randomized trial Int J Radiat Oncol Biol Phys 47 2000 925 929
16. Dautzenberg B., Arriagada R., and Boyer Chamard A. A controlled study of post-operative radiotherapy for patients with completely resected non-small cell lung carcinoma Cancer 86 1999 265 273
17. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized trials Br Med J 311 1995 899 909
18. Scagliotti G.V., Fossati R., and Torri V. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIa non-small cell lung cancer J Natl Cancer Inst 95 2003 1453 1461
19. The International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer N Engl J Med 350 2004 351 360
20. Abstract #7018 Winton T.L., Livingston R., and Johnson D. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage IB and II non small cell lung cancer (NSCLC) Intergroup JBR.10 Proc Am Soc Clin Oncol 2004
21. Abstract #7019 Strauss G.M., Herndon J., and Maddaus M.A. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carbopatin following resection in Stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633 Proc Am Soc Clin Oncol 2004
22. Wada H., Hitomi S., and Teramatsu T. Adjuvant chemotherapy after complete resection in non-small cell lung cancer J Clin Oncol 14 1996 1048 1054
23. Kato H., Ichinose Y., and Ohta M. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 2004 1713 1721
24. Keller S.M., Adak S., and Wagner H. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small cell lung cancer N Engl J Med 343 2000 1217 1222
25. Depierre A., Milleron B., and Moro-Sibilot D. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa nonsmall cell lung cancer J Clin Oncol 20 2002 247 253
26. Blum R.H. Adjuvant chemotherapy for lung cancer -- a new standard of care N Engl J Med 350 2004 404 405